MYD88 and depressive symptom measurement: In a study using a CUMS model of depression, the TLR4/MyD88/NF-κB and HIF-1α-VEGF signaling pathways in the hippocampus underwent significant changes, contributing to neuroinflammation and depressive behaviors [52,53].